Breast Cancer Research and Treatment
Published by Springer Nature
ISSN : 0167-6806 eISSN : 1573-7217
Abbreviation : Breast Cancer Res. Treat.
Aims & Scope
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication.
The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field.
It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3 |
2024 | 3.00 |
Journal Rank
Year | Value |
---|---|
2024 | 2882 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 3674 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.351 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Citation: 2214
Authors: Balazs, Andras, Aron C., Carsten, Jan, Qiyuan, Zoltan
-
The Nottingham prognostic index in primary breast cancer
Citation: 799
Authors: Marcus H., Roger W., Christopher E., Ian O.
-
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Citation: 768
Authors: Melinda, Michael, Jennifer H.
-
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Citation: 719
Authors: Dawn L., Theresa, Lawrence H., Donna, Wei Yann, Louis, Marilyn, Scarlett Lin, Alfred I.
-
Epidemiology of basal-like breast cancer
Citation: 666
Authors: Robert C., Beth, Chiu-Kit, Patricia G., Kathleen, Lisa V., Miriam H., Joseph, Jeannette T., Susan, Sarah, Chad, Lisa, H. Shelton, Charles M.
-
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Citation: 634
Authors: Lisa M., Douglas G., Willi, Sheila E., Massimo, Gary M.
-
Role of epidermal growth factor receptor in breast cancer
Citation: 623
Authors: Hiroko, Dongwei, Chandra, Hiroyoshi, Gabriel N., Naoto T.
-
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
Citation: 622
Authors: David, Michelle, Michael, Deborah, Tadeusz, C. Gilles, Stephen, Agnieszka, Bella, John, Arlene, Mario, Patrice, Neville, Vera, Johannes Isaac, Dimosthenis, Beth, Debasish, Paolo, Cristina, Stephen, Steven, Charles E.
-
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Citation: 604
Authors: Luc Y., Istvan, Guy, Petros, Hendrik-Tobias, Andres, Ralph, Marc E., Robert, Martin, Leisha A., Borys, William, Jayne, Anja, Hans Juergen, Kevin, Erika P.
-
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
Citation: 589
Authors: Marc, Guy